← All stocks

Core Scientific, Inc./tx

CORZ Net buying

CIK 0001839341 #1249 in the set updated 17 Sep 2026

Bought (1 mo)

$244.35K

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$895.90K

$895.90K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 5 sales

Net

−$651.55K

+$244.35K against sales at will

By person

13 insiders · 7 transactions

93.1×

Adam Sullivan holds 93.1 times base salary in stock. $76.02M of shares against $815.77K in salary for 2025.

Salary from the company's own proxy. The shares are what Adam Sullivan last reported holding, valued at $17.14, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

DUCHENE TODD M

See remarks

—

$895.90K (5) scheduled

−$895.90K

1,907,896

0.5937%

$32.69M

+12.6%

Weiss Eric Stanton

Director

$134.36K (1)

—

+$134.36K

259,262

0.0807%

$4.44M

+32.8%

CRAIN ELIZABETH

Director

$109.99K (1)

—

+$109.99K

71,348

0.0222%

$1.22M

—

Sullivan Adam Taylor

Chief Executive Officer

—

4,436,426

1.38%

$76.02M

+9.1%

Nygaard James P Jr

EVP, Chief Financial Officer

—

1,043,056

0.3246%

$17.87M

+432.1%

Rozov Yadin

Director

—

454,162

0.1413%

$7.78M

+77.9%

Sterling Denise Marie Brucia

Chief Financial Officer

—

440,028

0.1369%

$7.54M

−0.2%

Levy Jordan

Director

—

325,462

0.1013%

$5.58M

+45.3%

Patten Jarrod M

Director

—

320,448

0.0997%

$5.49M

+6.8%

Booth Jeffrey David

Director

—

214,262

0.0667%

$3.67M

+22.3%

Becker Todd A

Director

—

195,687

0.0609%

$3.35M

−36.8%

Adams Mark

Director

—

27,594

0.0086%

$472.86K

—

Smith Stephen M

Director

—

18,961

0.0059%

$324.92K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

CRAIN ELIZABETH

20 Aug 2026

Director

Buy

6,000

$18.33

$109.99K

Weiss Eric Stanton

18 Aug 2026

Director

Buy

7,000

$19.19

$134.36K

Show all 7 transactions →

What was left out

Form 4 filings counted 7

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 5

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 11,205

History held since 1 Jun 2022